Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to... see more

TSXV:SBM - Post Discussion

Sirona Biochem Corp > Pullans pieces SBM
View:
Post by LakeOromocto on Jun 28, 2022 1:23pm

Pullans pieces SBM

https://app.robly.com/archive?id=175610eac56dbcd1acc33b1cf99781e9&v=true Having Linda working with Michelle is a win win! Congrats to both.
Comment by biorun on Jun 28, 2022 1:28pm
Pullan has an important following.
Comment by MACNAC on Jun 28, 2022 1:40pm
Most important item I got from her article is that of all the current Big Pharma deals completed, 70% did not disclose the upfront payment. So SBM's deal is part of the majority in this case. 
Comment by Engcan77 on Jun 28, 2022 2:26pm
The connection with Linda and Dr Bieber has now put Sirona at the next level of respect in the Pharma world. IMO. Plus, the deal with Abbvie has done the same...it will give confidence to other companies to pay for Sirona's science. It shouldn't be taken lightly.  Sirona will be connected to a larger part of the Pharma world...so i see future deals will become alot smoother and ...more  
Comment by lscfa on Jun 28, 2022 3:11pm
What % of public co.s did not disclose no.s?     
Comment by MACNAC on Jun 28, 2022 4:00pm
Linda stated 58% did not disclose financials of the deals and 70% did not disclose the upfront payment. She did not mention which are public companies, but how many big pharma are not public? I have no clue.
Comment by lscfa on Jun 28, 2022 4:25pm
With no revenues, the upfront payment to Sirona will be revealed in next fins end of Sept. so why delay the inevitable.   
Comment by MirrorWorldMan on Jun 28, 2022 8:42pm
My guess is Sirona has already received the first tranche because of the giddiness of the news releases. That should be  in the financials. Diciphering longer term payments from the Notes is anybody's guess. Unless the financials become credible, are cleaned up and transparent, no fund managers will be able to justify a risky investment to their clients or peers. Even shorty, as nasty as ...more  
Comment by navajojoe on Jun 28, 2022 10:11pm
This post has been removed in accordance with Community Policy
Comment by biorun on Jun 28, 2022 11:03pm
or the Abbvie 10K in August? 
Comment by lscfa on Jun 28, 2022 2:15pm
The other deal she highlighted revealed no's........ https://www.prnewswire.com/news-releases/d-e-shaw-research-licenses-first-in-class-therapeutic-for-immunological-diseases-to-lilly-301566618.html     
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities